Papillary carcinomas account for the largest proportion of thyroid cancers, with papillary
thyroid carcinoma (PTC) being prone to early lymph node metastasis. Some studies have …

Background: Lysophosphatidic acid receptor 1 (LPAR1) has been identified as a biomarker
in various cancer types. However, its biological function in papillary thyroid carcinoma (PTC) …

Methods The expression of LPAR6 and its clinical characteristics were evaluated on various
databases. The association between LPAR6 and immune infiltrates of various types of …

Prostate cancer is a common malignancy in men worldwide. Lysophosphatidic acid receptor
1 (LPAR1) is a critical gene and it mediates diverse biologic functions in tumor. However, the …

Abstract Lysophosphatidic acid receptor 5 (LPAR5) is involved in mediating thyroid cancer
progression, but the underlying mechanism needs to be further revealed. In this study, we …

The incidence of thyroid cancer has increased the past few decades, the most frequent type
has been identified to be the papillary thyroid carcinoma (PTC). Following thyroidectomy …

The incidence of thyroid cancer has increased in recent decades. The potential molecular
mechanisms of papillary thyroid cancer (PTC) are still to be uncovered. In recent years, a …

Background: Thyroid cancer (THCA) is a prevalent form of cancer with high rates of
morbidity and mortality. The small GTPase ADP-ribosylation factor-like 4A (ARL4A) is …

Dysregulation of cell proliferation and death is considered the foundation of the malignant
biological characteristics of cancer. In this study, we conducted a comprehensive analysis of …

Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid
Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) …